Eighty-seven sites. Eighty-seven slightly different reads of your protocol. TrialPulse makes every site — across every country, through every amendment — operate from the same interpretation. Your medical monitor can't be everywhere. TrialPulse can.
Industry average to operationalize: 6.4 weeks.
Coordinators get protocol-aligned answers in seconds. Borderline cases resolve instantly instead of waiting on a monitor email.
Your study stays top-of-mind from SIV to last-subject-in — not buried under ten other protocols on a coordinator's desk.
Open cohorts surface to the right physicians by biomarker, at the point of care — turning passive sites into active referrers.
One live operating picture across the portfolio: decision time, comprehension, and confusion hotspots before they become deviations.
Beyond timelines and budget — the operational wins your sites feel at every decision point.
Every site—from Boston to Munich to Tokyo—interprets eligibility criteria identically. No more 'slightly different' enrollments. No more data inconsistency.
Real-time AI guidance catches eligibility errors at the point of decision—not months later during monitoring. Reduce preventable deviations by up to 40%.
Sites don't hesitate. Coordinators get protocol-aligned answers in 5 seconds. Borderline cases get resolved instantly. Enrollment velocity increases.
Sites stop over-excluding patients 'to be safe.' AI clarifies edge cases, reducing unnecessary screen failures and maximizing site budget efficiency.
Standardized eligibility interpretation reduces unconscious bias in screening. Sites confidently enroll underrepresented populations when criteria are crystal clear.
Fewer deviations = fewer queries = fewer corrective actions. CRAs spend less time on reactive problem-solving and more time supporting proactive site performance.
Continuous engagement through AI-powered protocol updates, training refreshers, and eligibility reminders. Your study doesn't get lost in the stack.
SIV materials and training videos stay accessible 24/7. New coordinators joining mid-study onboard in hours, not weeks—without relying on colleagues' fading memory.
Pilot TrialPulse on one study for 30 days. Measure PI engagement, screen-failure rate, and protocol clarity. Expand when the numbers prove it.
Tell us a little about your study and we'll tailor the demo to your protocol.